Peter Callow is a seasoned finance executive with extensive international experience in financial management, strategic planning, and leadership.
Professor Catherine Green OBE is Head of the Clinical Biomanufacturing Facility at Nuffield Department of Medicine and Associate Professor in Chromosome Dynamics at the Centre for Human Genetics, University of Oxford. She played a key role in developing the Oxford/AstraZeneca Covid-19 vaccine.
Professor Bethan Psaila is an Associate Professor of Haematology and Cancer Research at MRC Weatherall Institute of Molecular Medicine, University of Oxford; she is also Co-founder of a blood malignancies company and BioEscalator tenant Alethiomics.
Professor Molly Stevens DBE is John Black Professor of bionanoscience at the University of Oxford and research director for biomedical materials at Imperial College London.
Professor Krina Zondervan is Head of the Nuffield Department of Women's & Reproductive Health, Professor of Reproductive and Genomic Epidemiology, and Co-Director of the Endometriosis Care Centre, University of Oxford.
These five new Board members bring a wealth of medical sciences expertise and skills to the BioEscalator, which will have a positive impact on tenants and the University of Oxford research activity. We welcome them to the Management Board and look forward to working with them on innovation activities.
Professor of Neuroscience and Entrepreneur Matthew Wood, Chair of the Board